AKT1 and breast carcinoma: The miR-1/133a cluster has been shown to be downregulated in a variety of cancers, whereas miRNA-133a has also been shown to act as a tumour suppressor in breast cancer cells by causing S/G2 phase cell-cycle arrest through activity on phosphorylated Akt [28, 29].